Document Type : Original Article
Authors
1 Student Research Committee, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Mashhad Medical Microbiology Student Research Group, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Microbiology Laboratory, Central Laboratory, Imam Reza Hospital, Mashhad, IR Iran
Abstract
Keywords
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
1. Cookson B, Bonten MJ, Mackenzie FM, Skov RL, Verbrugh HA, Tacconelli E, et al. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents. 2011;37(3):195-201. [PubMed: 21163631] https://doi.org/10.1016/j.ijantimicag.2010.10.023 PMid:21163631 |
||||
2. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-55. [PubMed: 21208910] https://doi.org/10.1093/cid/ciq146 PMid:21208910 |
||||
3. Arianpoor A et al. Razavi Int J Med. 2015;3(4):e31568 25 https://doi.org/10.17795/rijm31568 |
||||
4. Shlaes DM, Spellberg B. Overcoming the challenges to developing new antibiotics. Curr Opin Pharmacol. 2012;12(5):522-6. [PubMed: 22832234] https://doi.org/10.1016/j.coph.2012.06.010 PMid:22832234 |
||||
5. van Hal SJ, Fowler VG. Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections? Clin Infect Dis. 2013;56(12):1779-88. [PubMed: 23511300] https://doi.org/10.1093/cid/cit178 PMid:23511300 PMCid:PMC3658366 |
||||
6. Askari E, Tabatabai SM, Arianpoor A, Nasab MN. VanA-positive vancomycin-resistant Staphylococcus aureus: systematic search and review of reported cases. Infect Dis Clin Prac. 2013;21(2):91-3. https://doi.org/10.1097/IPC.0b013e31826e8199 |
||||
7. Rossi F, Diaz L, Wollam A, Panesso D, Zhou Y, Rincon S, et al. Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med. 2014;370(16):1524-31. [PubMed: 24738669] https://doi.org/10.1056/NEJMoa1303359 PMid:24738669 PMCid:PMC4112484 |
||||
8. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001;1(3):147- 55. [PubMed: 11871491] https://doi.org/10.1016/S1473-3099(01)00091-3 PMid:11871491 |
||||
9. Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, et al. Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States. Antimicrob Agents Chemother. 2014;58(2):740-5. [PubMed: 24247138] https://doi.org/10.1128/AAC.01915-13 PMid:24247138 PMCid:PMC3910823 |
||||
10. Yu F, Lu C, Liu Y, Sun H, Shang Y, Ding Y, et al. Emergence of quinupristin/dalfopristin resistance among livestock-associated Staphylococcus aureus ST9 clinical isolates. Int J Antimicrob Agents. 2014;44(5):416-9. [PubMed: 25218154] https://doi.org/10.1016/j.ijantimicag.2014.06.020 PMid:25218154 |
||||
11. Askari E, Soleymani F, Arianpoor A, Tabatabai SM, Amini A, Naderinasab M. Epidemiology of mecA-Methicillin Resistant Staphylococcus aureus (MRSA) in Iran: A Systematic Review and Meta-analysis. Iran J Basic Med Sci. 2012;15(5):1010-9. [PubMed: 23493646] | ||||
12. Sanchez Garcia M, De la Torre MA, Morales G, Pelaez B, Tolon MJ, Domingo S, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010;303(22):2260- 4. [PubMed: 20530779] https://doi.org/10.1001/jama.2010.757 PMid:20530779 |
||||
13. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother. 2013;68(1):4-11. [PubMed: 22949625] https://doi.org/10.1093/jac/dks354 PMid:22949625 PMCid:PMC8445637 |
||||
14. Ruzbahani M, Rahdar HA, Babaei Z, Rezaeyan MH, Jafari M, Rezai M. Identification of Antibiotic Resistance Patterns of MethicillinResistant Staphylococcus Aureus Isolates from Patients in Selected Hospitals in Isfahan. Glob J Med Res Stud. 2014;1(2):37-40. | ||||
15. Shahsavan S, Emaneini M, Noorazar Khoshgnab B, Khoramian B, Asadollahi P, Aligholi M, et al. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients. Burns. 2012;38(3):378-82. [PubMed: 22040930] https://doi.org/10.1016/j.burns.2011.09.004 PMid:22040930 |
||||
16. Dibah S, Arzanlou M, Jannati E, Shapouri R. Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran. Iran J Microbiol. 2014;6(3):163-8. [PubMed: 25870749] | ||||
17. Rahimi F, Bouzari M, Katouli M, Pourshafie MR. Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates in Tehran, Iran. Jundishapur J Microbiol. 2013;6(2):144-9. https://doi.org/10.5812/jjm.4896 |
||||
18. Luh KT, Hsueh PR, Teng LJ, Pan HJ, Chen YC, Lu JJ, et al. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob Agents Chemother. 2000;44(12):3374-80. [PubMed: 11083643] https://doi.org/10.1128/AAC.44.12.3374-3380.2000 PMid:11083643 PMCid:PMC90208 |
||||
19. Kali A, Stephen S, Umadevi S, Kumar S. Detection of quinupristindalfopristin resistance in methicillin-resistant Staphylococcus aureus in South India. Indian J Pathol Microbiol. 2013;56(1):73-4. [PubMed: 23924572] https://doi.org/10.4103/0377-4929.116164 PMid:23924572 |
||||
20. Hassanzadeh S, Pourmand MR, Hadadi A, Nourijeylani K, Yousefi M, Mashhadi R, et al. Frequency and Antimicrobial Resistance Patterns of Methicillin-Resistant Staphylococcus aureus in Tehran. J Med Bacteriol. 2013;2(3, 4):41-6. | ||||
21. Yin LY, Lazzarini L, Li F, Stevens CM, Calhoun JH. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother. 2005;55(6):995-1002. [PubMed: 15857944] https://doi.org/10.1093/jac/dki109 PMid:15857944 |
||||
22. Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycinresistant enterococci: a Phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother. 2008;62 Suppl 1:i17-28. [PubMed: 18684703] https://doi.org/10.1093/jac/dkn250 PMid:18684703 |
||||
23. Verkade EJ, Verhulst CJ, Huijsdens XW, Kluytmans JA. In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains. Eur J Clin Microbiol Infect Dis. 2010;29(5):503-7. [PubMed: 20186450] https://doi.org/10.1007/s10096-010-0886-2 PMid:20186450 PMCid:PMC2854363 |